Posted by Maxim Biomedical, Inc.
Maxim Biomedical was pleased to be among the thousands of exhibitors and attendees at this year 2016 AACC Conference in Philadelphia, PA between 08/02/16 – 08/04/16. Thank you for your positive feedback on our newest prototype LAg LFI Kit and Reader which we unveiled at this year’s conference. See below for our 2016 AACC flyers:
· 2016 AACC – Antigens & Antibodies·
· 2016 AACC – LAg-Avidity LFI for HIV-1 Incidence
· 2016 AACC – CMO/CRO Services Customized for You
Maxim Biomedical was mentioned at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI). See the abstract and poster presented!
Our 2 year audit for FDA cGMP was performed and approved by FDA.
Our annual renew audit for ISO 13485:2003 was performed and approved by G-MED.
Maxim Biomedical, Inc. becomes the first company in the nation to be CDC approved for HIV-1 LAg-Avidity DBS and Serum/Plasma EIA Kits.